Considering Both GLS and MD for a Prognostic Value in Non-ST-Segment Elevated Acute Coronary Artery Syndrome

Ioana Ionac1, Mihai-Andrei Lazăr1,2, Raluca Șoșdean1,2

  • 1Cardiology Department, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Insights

The novel GLS/MD index predicts outcomes in non-ST-segment elevated acute coronary syndrome (NSTE-ACS) patients. A worsening GLS/MD ratio after discharge indicates a significantly worse prognosis for cardiac events.

Area of Science:

  • Cardiology
  • Echocardiography
  • Cardiovascular Imaging

Background:

  • Global longitudinal strain (GLS) and mechanical dispersion (MD) are established prognostic markers in cardiovascular diseases.
  • Limited research exists on the prognostic value of GLS and MD in non-ST-segment elevated acute coronary syndrome (NSTE-ACS) patients.

Purpose of the Study:

  • To evaluate the predictive capability of a new GLS/MD two-dimensional strain index in patients with NSTE-ACS.
  • To assess the prognostic significance of changes in the GLS/MD index from discharge to follow-up.

Main Methods:

  • 310 consecutive NSTE-ACS patients undergoing successful percutaneous coronary intervention (PCI) were studied.
  • 2D speckle tracking echocardiography was performed at discharge and 4-6 weeks later.
  • Major endpoints included cardiac mortality, ventricular arrhythmia, heart failure readmission, and reinfarction.

Main Results:

  • The GLS/MD index at discharge was the strongest independent predictor of composite outcomes (cutoff: -0.229).
  • A GLS/MD index > -0.229 that deteriorated at follow-up was associated with the worst prognosis.
  • Kaplan-Meier analysis showed significantly worse outcomes for patients with deteriorating GLS/MD (p < 0.001).

Conclusions:

  • The GLS/MD ratio is a potent predictor of clinical outcomes in NSTE-ACS patients.
  • Deterioration of the GLS/MD index post-discharge signifies a particularly poor prognosis.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
19
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
31
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
46
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
216
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
19
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
34